oral liposomal bpc-157 – Oral Liposomal BPC + KPV

Never use the pen if the medication is frozen or cloudy

While a causal relationship has not been established, patients with depression or other psychiatric conditions should be monitored for changes in mood or behavior, particularly during the initial weeks of treatment or following dose adjustments

Patients should inform their healthcare provider of all medical conditions, medications, and supplements prior to receiving this compounded formulation

Vukusic D et al

The reserve capacity is 4 to 10 days

Properly designed clinical trials with nerve conduction studies, quantitative sensory testing, and symptom assessments would evaluate BPC-157's potential for peripheral nerve disorders